Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study.

[1]  M. Pfeffer,et al.  Human pharmacokinetics of sotalol. , 2009, Acta pharmacologica et toxicologica.

[2]  N. Rehnqvist,et al.  Ventricular arrhythmias during the first year after acute myocardial infarction: influence of long-term treatment with metoprolol. , 1984, Circulation.

[3]  R. Harrist,et al.  Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. , 1983, Circulation.

[4]  D. Harrison,et al.  Prolongation of the human cardiac monophasic action potential by sotalol. , 1982, The American journal of cardiology.

[5]  D. Bennett.  Acute prolongation of myocardial refractoriness by sotalol. , 1982, British heart journal.

[6]  A. Camm,et al.  Electrophysiological effects of sotalol--just another beta blocker? , 1982, British heart journal.

[7]  B. Lown,et al.  Mexiletine for ventricular arrhythmias. , 1981, The American journal of cardiology.

[8]  P. Denes,et al.  Chronic ventricular arrhythmias: comparative drug effectiveness and toxicity. , 1980, Progress in cardiovascular diseases.

[9]  J. Federman,et al.  The effect of a selective beta adrenergic blocking agent on ventricular arrhythmias in the first year following myocardial infarction. , 1980, Australian and New Zealand journal of medicine.

[10]  E. Michelson,et al.  Spontaneous Variability of Complex Ventricular Arrhythmias Detected by Long‐term Electrocardiographic Recording , 1980, Circulation.

[11]  A. Goldman,et al.  The efficacy of sotalol in suppressing ventricular ectopic beats. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[12]  A. Simon,et al.  Long‐Term Sotalol Therapy in Patients with Arrhythmias , 1979, Journal of clinical pharmacology.

[13]  R. Winkle,et al.  Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine. , 1978, The American journal of cardiology.

[14]  L. Horowitz,et al.  Electrocardiographic Findings in Patients with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy , 1978, Circulation.

[15]  Y. Latour,et al.  Effects of sotalol in twenty patients with cardiac arrhythmias. , 1977, International journal of clinical pharmacology and biopharmacy.

[16]  M. Bogaert,et al.  Therapeutic effectivenss and plasma levels of aprindine, a new antidysrhythmic drug , 1974, European Journal of Clinical Pharmacology.

[17]  S. Dahl,et al.  A new sustained-release tablet formulation of procainamide , 1973, European Journal of Clinical Pharmacology.

[18]  B. Singh,et al.  A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 , 1970, British journal of pharmacology.

[19]  J. Kastor,et al.  Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. , 1969, The New England journal of medicine.